RODEK JEFFREY R
Known title: DirectorCIK: 0001233406
Associated companies
Transaction History
| SCSC | ▲ Buy | Grant | 3,234 | $0 | 9/1/2026 | View on chart |
| SCSC | ▲ Buy | Grant | 3,693 | $0 | 9/1/2025 | View on chart |
| SCSC | ▲ Buy | Grant | 3,141 | $0 | 8/30/2024 | View on chart |
| SCSC | ▲ Buy | Grant | 4,759 | $150K | 8/25/2023 | View on chart |
| SCSC | ▲ Buy | Grant | 5,300 | $152K | 8/26/2022 | View on chart |
| SCSC | ▲ Buy | Grant | 3,700 | $133K | 8/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Barclays Raises ScanSource Price Target to $51
Barclays maintained an Equal-Weight rating on ScanSource while raising its price target to $51. The firm highlighted the company's position within the technology services sector, which continues to face industry-wide challenges. This update provides a specific valuation benchmark for investors, sitting below the current average analyst target of $64.50.
Barclays Raises ScanSource Price Target to $51. Barclays maintained an Equal-Weight rating on ScanSource while raising its price target to $51. The firm highlighted the company's position within the technology services sector, which continues to face industry-wide challenges. This update provides a specific valuation benchmark for investors, sitting below the current average analyst target of $64.50.